Table 3—

St George's Respiratory Questionnaire (SGRQ), Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36) and Transition Dyspnea Index (TDI) focal score results at the end of the trial in the ipratropium and tiotropium groups

	Ipratropium	Tiotropium	Difference	95% CI	p-value
SGRQ
Symptoms	50.47±1.49	47.32±1.07	−3.15±1.73	−6.55–0.26	0.070
Activities	56.21±1.17	55.07±0.84	−1.14±1.36	−3.82–1.53	0.401
Impacts	35.23±1.14	30.95±0.81	−4.28±1.32	−6.87–−1.68	0.001
Total	44.20±0.97	40.90±0.69	−3.30±1.13	−5.51–−1.09	0.004
SF-36
Physical function	52.20±1.40	54.32±1.00	2.11±1.62	−1.08–5.30	0.194
Role physical	49.46±2.88	56.62±2.05	7.16±3.34	0.59–13.73	0.033
Bodily pain	76.57±1.69	79.47±1.21	2.89±1.96	−0.96–6.75	0.141
General physical health	47.01±1.29	49.89±0.92	2.88±1.50	−0.06–5.82	0.055
Physical health summary	38.49±0.59	40.16±0.42	1.68±0.69	0.33–3.02	0.015
Vitality	57.56±1.25	60.35±0.89	2.79±1.45	−0.06–5.64	0.055
Social function	74.68±1.75	76.07±1.25	1.39±2.02	−2.59–5.37	0.493
Role emotional	63.86±2.95	70.29±2.10	6.44±3.42	−0.28–13.15	0.060
General mental health	75.40±1.17	76.12±0.84	0.71±1.36	−1.96–3.39	0.600
Mental health summary	50.90±0.70	51.82±0.50	0.93±0.82	−0.68–2.53	0.258
TDI
Focal score	−0.44±0.23	0.46±0.16	0.90±0.26	0.37–1.41	0.001

Data are presented as mean±sem or range
CI: confidence interval